STAT3 and liver cancer: Consistently, HDAC3 knockdown in human liver cancer cells HepG2 using siRNA significantly increased ac-STAT3 expression level and remarkably inhibited cell growth (Fig. 4c; Supplementary Fig. 8a–c).